Cargando…

MYH Gene Status in Polish FAP Patients without APC Gene Mutations

Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the APC gene. Screening for genetic factors in persons without...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrzypczak, Marzena, Podralska, Marta, Heinritz, Wolfram, Froster, Ursula G, Lipiński, Daniel, Słomski, Ryszard, Pławski, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401920/
https://www.ncbi.nlm.nih.gov/pubmed/20223003
http://dx.doi.org/10.1186/1897-4287-4-1-43
_version_ 1782238682312343552
author Skrzypczak, Marzena
Podralska, Marta
Heinritz, Wolfram
Froster, Ursula G
Lipiński, Daniel
Słomski, Ryszard
Pławski, Andrzej
author_facet Skrzypczak, Marzena
Podralska, Marta
Heinritz, Wolfram
Froster, Ursula G
Lipiński, Daniel
Słomski, Ryszard
Pławski, Andrzej
author_sort Skrzypczak, Marzena
collection PubMed
description Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the APC gene. Screening for genetic factors in persons without mutations in the APC gene led to the identification of homozygotic mutations of the MYH gene as the cause of the appearance of the polyposis form which is characterized by recessive heritability and a milder course than in the case of the classic form of the disease. The authors examined 90 persons from the DNA bank of patients with FAP from the Institute of Human Genetics of the Polish Academy of Sciences in Poznań in whom no mutations in the APC gene were detected. Two of the most frequent mutations of the MYH gene (Y165C and G382D) were found to be heterozygous in 13% of patients and no other mutations in this gene coding sequence were observed. In the group with heterozygotic occurrence of the mutation in the MYH gene, the disease phenotype was not milder in comparison with the entire examined group and the mean age of the disease manifestation was even lower. This observation allows one to conclude that the employed methods of mutation screening were correct and, in the case of the examined group, the mutation ratio of the MYH gene does not precondition the occurrence of the disease, but it cannot be excluded that it may modify its phenotype. The obtained results indicate that the criteria applied during the process of FAP qualification are more rigorous than those applied in other countries.
format Online
Article
Text
id pubmed-3401920
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34019202012-07-24 MYH Gene Status in Polish FAP Patients without APC Gene Mutations Skrzypczak, Marzena Podralska, Marta Heinritz, Wolfram Froster, Ursula G Lipiński, Daniel Słomski, Ryszard Pławski, Andrzej Hered Cancer Clin Pract Research Familial Adenomatous Polyposis (FAP) is an inheritable predisposition for the occurrence of numerous polyps in the large intestine. In about 50% of all patients, the occurrence of the disease is conditioned by heterozygotic mutations of the APC gene. Screening for genetic factors in persons without mutations in the APC gene led to the identification of homozygotic mutations of the MYH gene as the cause of the appearance of the polyposis form which is characterized by recessive heritability and a milder course than in the case of the classic form of the disease. The authors examined 90 persons from the DNA bank of patients with FAP from the Institute of Human Genetics of the Polish Academy of Sciences in Poznań in whom no mutations in the APC gene were detected. Two of the most frequent mutations of the MYH gene (Y165C and G382D) were found to be heterozygous in 13% of patients and no other mutations in this gene coding sequence were observed. In the group with heterozygotic occurrence of the mutation in the MYH gene, the disease phenotype was not milder in comparison with the entire examined group and the mean age of the disease manifestation was even lower. This observation allows one to conclude that the employed methods of mutation screening were correct and, in the case of the examined group, the mutation ratio of the MYH gene does not precondition the occurrence of the disease, but it cannot be excluded that it may modify its phenotype. The obtained results indicate that the criteria applied during the process of FAP qualification are more rigorous than those applied in other countries. BioMed Central 2006-01-15 /pmc/articles/PMC3401920/ /pubmed/20223003 http://dx.doi.org/10.1186/1897-4287-4-1-43 Text en
spellingShingle Research
Skrzypczak, Marzena
Podralska, Marta
Heinritz, Wolfram
Froster, Ursula G
Lipiński, Daniel
Słomski, Ryszard
Pławski, Andrzej
MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title_full MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title_fullStr MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title_full_unstemmed MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title_short MYH Gene Status in Polish FAP Patients without APC Gene Mutations
title_sort myh gene status in polish fap patients without apc gene mutations
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401920/
https://www.ncbi.nlm.nih.gov/pubmed/20223003
http://dx.doi.org/10.1186/1897-4287-4-1-43
work_keys_str_mv AT skrzypczakmarzena myhgenestatusinpolishfappatientswithoutapcgenemutations
AT podralskamarta myhgenestatusinpolishfappatientswithoutapcgenemutations
AT heinritzwolfram myhgenestatusinpolishfappatientswithoutapcgenemutations
AT frosterursulag myhgenestatusinpolishfappatientswithoutapcgenemutations
AT lipinskidaniel myhgenestatusinpolishfappatientswithoutapcgenemutations
AT słomskiryszard myhgenestatusinpolishfappatientswithoutapcgenemutations
AT pławskiandrzej myhgenestatusinpolishfappatientswithoutapcgenemutations